Accordingly, introduction of FGFR4-KD(K504M) impaired GBM clonogenicity and cell proliferation, especially in the endogenously FGFR4high glioma models (Fig. 3F, Additional File 1: Figure S7C, respectively). This evidence concerns the gene FGFR4 and glioblastoma.